Press Releases

Stay Updated

Press Releases

STATEMENT: Drug Companies Continue To Raise Prices At Will; Congress Must Act

WASHINGTON, D.C. — In response to reports that Big Pharma kicked off the year with increased prices on 442 drugs and more price hikes expected, David Mitchell, a cancer patient and founder of Patients For Affordable Drugs, issued the following statement: “At a time when Americans are struggling with the surging omicron variant and prices […]

Press Releases

PRESS CONFERENCE: P4AD’s David Mitchell Says House Oversight Committee Report Drives Home Need For Swift Senate Passage Of BBB To Reform Broken Drug Pricing System

WASHINGTON, D.C. — Cancer patient and founder of Patients For Affordable Drugs David Mitchell joined House Oversight and Reform Committee Chairwoman Carolyn Maloney, Speaker Nancy Pelosi, congressional leaders, and advocates at a press conference today that revealed the final findings from the committee’s nearly three-year investigation into pharmaceutical pricing and business practices. The committee’s findings sharply […]

Press Releases

ICYMI: New Video Tells The Truth About COVID-19 Vaccines

WASHINGTON, D.C. — As Big Pharma is working overtime to sell the story that drug corporations saved us from COVID-19 by developing new vaccines, Patients For Affordable Drugs released a new video and fact sheet this week explaining the mRNA vaccines’ true origin story. The truth is the federal government invested billions of dollars to make […]

Press Releases

RELEASE: Setting The Record Straight — New Fact Check Exposes Big Pharma’s Lies About Medicare Negotiation

WASHINGTON, D.C. — Patients For Affordable Drugs released an extensive fact check today that takes on Big Pharma’s lies in recent ads, which total more than $18 million this year, attacking drug pricing reforms that include allowing Medicare to negotiate lower drug prices. The fact check breaks down six false claims in pharma-funded ads, including misleading […]

Press Releases

STATEMENT: P4AD Applauds FDA’s Approval Of First Interchangeable Biosimilar Insulin, Calls For Affordable Insulin For All

WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs, in response to the Food and Drug Administration’s approval of Mylan’s Semglee as an interchangeable biosimilar to Sanofi’s long-acting Lantus (glargine) insulin: “The FDA’s approval of Semglee as an interchangeable biosimilar to Lantus is an […]

Press Releases

NEW ANALYSIS: Drug Companies Continue To Hike Prices At Will; Congress Must Act

WASHINGTON, D.C. — As the drug industry continues to hike drug prices at will, a new analysis from Patients For Affordable Drugs gives evidence of the urgent need for Congress to lower drug prices by allowing Medicare to negotiate directly with drug companies. The analysis explores more than 1,000 price hikes since the beginning of 2021 […]